17.4 C
New York
Tuesday, June 9, 2026

Tag: online

The Herald Group: Korea National Open University Opens Applications for Overseas Residents for Fall 2026

- "Earn a Degree from a Korean National University Online"SEOUL, South Korea, June 8, 2026 /PRNewswire/ -- Korea National Open University (KNOU), South Korea's...

Tethis to launch SmartBioSurface® slides at EACR Conference

MILAN, June 8, 2026 /PRNewswire/ -- Tethis S.p.A., a pioneering life sciences and diagnostics company, today announces the commercial launch of SmartBioSurface slides, an...

Arrivia and KrisFlyer Expand Partnership to Launch Cruise Redemptions with Miles

SINGAPORE, June 8, 2026 /PRNewswire/ -- arrivia and KrisFlyer, the lifestyle rewards programme of the Singapore Airlines Group, are elevating member benefits with the...

The 34th Eye Level Literary Awards Opens Global Literary Submissions

SEOUL, South Korea, June 8, 2026 /PRNewswire/ -- Daekyo Culture Foundation and the World Youth Culture Foundation announce the opening of submissions for the 34th...

Wegovy® pill prescriptions surpass 3 million, 1 filled roughly every 5 seconds, bringing GLP-1 therapy to people with obesity previously untreated, while Novo Nordisk...

Three million prescriptions for Wegovy® pill since launch on January 5th serves as another milestone in one of the strongest US pharmaceutical launches by...

Vision Insurance After Retirement (2026): VSP Vision Care Named Leading Option for Retiree Eye Coverage by Expert Consumers

NEW YORK, June 7, 2026 /PRNewswire/ -- A recent analysis from Expert Consumers highlights VSP® Vision Care as a leading option for vision insurance...

Futu Investor News: If You Have Suffered Losses in Futu Holdings Limited (NASDAQ: FUTU), You Are Encouraged to Contact The Rosen Law Firm About...

NEW YORK, June 07, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Futu Holdings Limited (NASDAQ: FUTU) resulting from allegations that Futu may have issued materially misleading business information to the investing public.

SlimTide Capsules [UPDATED WARNING 2026] Slim Tide Uncovering the Real Truth Behind the Trending Weight Loss Supplement

This SlimTide investigation uncovers the science behind its 800 mg BHB ketone blend for weight loss and exposes critical red flags consumers must know before buying Slim Tide online.
This SlimTide investigation uncovers the science behind its 800 mg BHB ketone blend for weight loss and exposes critical red flags consumers must know before buying Slim Tide online.

University of Phoenix researchers publish study examining doctoral students’ attitudes toward AI chatbots and ChatGPT use in higher education

Peer-reviewed study by Center for Educational and Instructional Technology Research team highlights connections between student perceptions of AI, academic integrity concerns and reported chatbot...

Her Bodhi Claims Evaluated: What Research Reveals About This Primal Queen Alternative, Weight Loss Support and Consumer Reviews

An independent, research-informed evaluation of the Her Bodhi botanical formula — examining its ingredient benefits, weight loss positioning, menopause wellness support, disclosed side effects, and publicly available consumer feedback.
An independent, research-informed evaluation of the Her Bodhi botanical formula — examining its ingredient benefits, weight loss positioning, menopause wellness support, disclosed side effects, and publicly available consumer feedback.

Chandigarh University holds 8th CU Online Annual Convocation; 363 Students Degrees Awarded

Chandigarh University Sings MoU with Global Consulting Giant PwC to Offer Online MBA Program330 Postgraduate and 33 Undergraduate Degrees Conferred to Online and Distance...

Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress

Clinical benefit, including remissions, demonstrated in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) patients following a single target dose of CLN-978 

Ractigen Therapeutics Announces ADA 2026 Late-Breaking Presentation Highlighting saRNA as a New Frontier in Obesity Control

Breakthrough preclinical data demonstrate that LiCO-saUcp1 effectively turns white fat into calorie-burning brown fat, driving massive fat loss while fully preserving lean muscle mass...

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsOnline